What this means
This review explains three aging-related ideas and how they may link to rheumatoid arthritis. It says causal proof in people is still limited, and much evidence comes from animal and non-arthritis studies.
Plain-English summary written by an AI model from the abstract. The original is below.
- Who it was tested in
- A review of earlier studies
- Kind of research
- A summary of earlier studies
The science
- Original title
- The role of immune aging in rheumatoid arthritis and its clinical and therapeutic significance.
- Authors
- Wei Y, Qi W, Li P et al.
- Journal
- International immunopharmacology
- Published
- Oct 12, 2026
- Study type
- Review
- PMID
- 42863418 ↗
Abstract
Rheumatoid arthritis (RA) is a chronic autoimmune disease, and its onset and progression are closely related to age-related remodeling of the immune system. Immunosenescence refers to age-related changes in the overall structure and function of the immune system; inflammaging is a persistent, low-grade, systemic inflammatory state; cellular senescence refers to a relatively stable cell cycle arrest and functional remodeling of cells under continuous stress. These three are interrelated but correspond to the immune system, systemic inflammatory environment, and cellular state, respectively; therefore, they should not be used interchangeably. In RA, especially elderly-onset RA (EORA), immune age-related changes may occur earlier or be more severe. Human studies on RA mainly support that immune cell lineage remodeling, senescence-associated cell phenotypes, and changes in inflammatory mediators are associated with disease activity, structural damage, and some extra-articular comorbidities. Immunosenescence may compromise T-cell, B-cell, and innate immune functions; concurrently, local cellular senescence and the senescence-associated secretory phenotype (SASP) may drive synovial and bone marrow microenvironment remodeling, while inflammaging may further amplify systemic inflammation. Impaired immune clearance, accumulation of senescent cells, and SASP release may establish a self-perpetuating cycle and are associated with autoantibody production, bone loss, cartilage damage, and cardiovascular and neuropsychiatric comorbidities. However, causal evidence for SASP-driven RA synovitis and the efficacy of senolytic interventions is still primarily derived from experimental arthritis, osteoarthritis, and other non-RA disease models. This article clarifies the definitions and delineates the applicable boundaries of these three terms, reviews their systemic phenotypes, cell lineage characteristics, and molecular basis in RA, especially EORA, analyzes the links between immune age and disease activity, autoantibodies, synovial microenvironment, bone and cartilage damage, and extra-articular manifestations, and evaluates the potential benefits, risks, and evidence limitations of traditional disease-modifying antirheumatic drugs (DMARDs), biologic agents, and emerging senescence-targeting strategies. By constructing an integrated framework covering immune system remodeling, local cellular senescence, inflammatory amplification, and clinical outcomes, this article aims to provide a theoretical basis for further research on EORA risk stratification and immunosenescence-related interventions, rather than directly translating unverified mechanisms into clinical conclusions.
Wei Y, Qi W, Li P et al. The role of immune aging in rheumatoid arthritis and its clinical and therapeutic significance. International immunopharmacology. 2026. doi:10.1016/j.intimp.2026.117531. PMID: 42863418. https://pubmed.ncbi.nlm.nih.gov/42863418/
Related research
New fluorescent sensor detects cells aging from cancer and lung drugs
Researchers built a glowing probe that lights up only in certain aged cells. It may help scientists track these cells in living animals, but this is early lab work.
Mixing a senescence-clearing drug with trametinib slowed glioma regrowth in mice
Researchers found a drug combination that cleared aging-like tumour cells in mice and slowed regrowth. This does not show the combination would work the same way in children.
A vaccine-style treatment in mice eased diabetes signs and aged cell markers
Mice given a treatment aimed at a virus-like gene showed less weight gain and better blood sugar control. This study was in mice and cells, so it does not show the same would happen in people.
Aging cells that support stem cells may disrupt them through chemical signals
This is a review that pulls together older and newer studies. It proposes a model, but it does not show that the model is true.
Cx43 protein may boost breast cancer drug response in lab tests
Researchers studied a protein called Cx43 that helps cells talk to each other. They found it may help a breast cancer drug slow tumor growth. This early work is not yet checked by other scientists, so it does not show this would help people.
A new vaccine clears aging cells in mice and may extend lifespan
Researchers made a vaccine aimed at old, worn-out cells called senescent cells. In mice, it cleared some of these cells and helped metabolism. This is early work, so it does not show the vaccine would help people.
See all research on Senolytics →